Cargando…
A novel chemotherapeutic protocol for peritoneal metastasis and inhibition of relapse in drug resistant ovarian cancer
The majority of ovarian cancer patients are diagnosed in late stages of the disease, in which the tumor cells have leaked into the peritoneum and are present as tumorspheres. These tumorspheres are rich in cancer stem‐like cells (CSCs), which are resistant to therapy and are a major source of relaps...
Autores principales: | Sarkar, Siddik, Malekshah, Obeid M., Nomani, Alireza, Patel, Niket, Hatefi, Arash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089146/ https://www.ncbi.nlm.nih.gov/pubmed/29926538 http://dx.doi.org/10.1002/cam4.1631 |
Ejemplares similares
-
Drug-free In vitro Activation for Primary Ovarian Insufficiency
por: Patel, Niket H., et al.
Publicado: (2021) -
Risk of Ovarian Cancer Relapse Score: A Prognostic Algorithm to Predict Relapse Following Treatment for Advanced Ovarian Cancer
por: Rizzuto, Ivana, et al.
Publicado: (2015) -
CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
por: Farge, Thomas, et al.
Publicado: (2023) -
Transforming growth factor-β(1) induces connective tissue growth factor expression and promotes peritoneal metastasis of gastric cancer
por: Lv, Ling, et al.
Publicado: (2020) -
Peritoneal or mesenteric tumours revealing histiocytosis
por: Cohen-Aubart, Fleur, et al.
Publicado: (2021)